-
Abbreviations
- APP
- amyloid precursor protein
- BAK
- BCL-2 homologous antagonist/killer
- BAX
- BCL-2-associated (protein) X
- BID
- BH3 interacting-domain death agonist
- tBID
- truncated BID
- Debcl
- death executioner BCL-2
- DR6
- death receptor 6
- ER
- endoplasmic reticulum
- dsRNA
- double-stranded RNA
- HGF/SF
- hepatocyte growth factor/scatter factor
- Met
- protein kinase Met
- MIMP
- Met-induced mitochondrial protein
- MTCH
- mitochondrial carrier homolog
- PSAP
- presenilin 1-associated protein
- PSAPL
- large isoform of PSAP
- PSAPS
- short isoform of PSAP
- SMAC
- second mitochondria-derived activator of caspase
Apoptosis is a type of programmed cell death required for development and tissue homeostasis in multicellular organisms and therefore involved in several pathologies. In mammals, two major apoptotic pathways have been described, one involves mitochondria as a reservoir of proteins which trigger a cascade of apoptotic events, the so-called intrinsic pathway [1], while the other depends on cell surface receptors which are part of the extrinsic or death receptor pathway [2]. In some cells, both pathways are connected by BID, a protein that, upon cleavage by extrinsic pathway-activated cysteine-aspartate proteases (caspases), translocates to mitochondria as truncated BID (tBID) to activate the intrinsic pathway [3,4]. At the outer mitochondrial membrane tBID interacts with MTCH2 [5], a protein belonging to the mitochondrial inner membrane carrier family SLC25 [6]. MTCH2 was initially reported as MIMP (Met-induced mitochondrial protein; [7]), a protein whose expression increases when hepatocyte growth factor (HGF) binds to its specific receptor at the cell surface. MTCH2 knockout in mice has shown that it is required to recruit tBID to mitochondria [5], being, therefore, involved in apoptosis triggering. MTCH2 also modulates the body mass index [8], likely through lipid metabolism [9], being reported as a regulator of lipid homeostasis that influences the activity of estrogen receptor 1 [10]. Landgraf et al. [11] had previously shown that MTCH2 is involved in liver and intestine development in zebrafish, likely through alteration of Met-HGF/SF signal transduction. In pigs, modification of MTCH2 mRNA by N6-methyladenosine (m6A) promotes adipogenesis in intramuscular preadipocytes [12]. Labbé et al. [13] reported that MTCH2 is a regulator of mitochondrial fusion in response to lysophosphatidic acid, inducing hyperfusion in response to starvation, suggesting that it may be antagonizing the function of another outer membrane protein of the SLC25 family, SLC25A46 [14], which participates in lipid transfer between the ER and mitochondria, being involved in Leigh syndrome [15,16]. Despite its sequence homology with inner membrane transporters no function in metabolite transport has been so far assigned to MTCH2. This is due to the lack of the charged amino acids that form salt-bridges, essential for metabolite transport in these carrier-like outer membrane proteins [17,18].
MTCH1, a MTCH2 homolog, was initially reported as a presenilin-1 interacting protein (PSAP) [19]. Presenilin-1 is a component of the gamma secretase complex and is involved in the proteolysis of several integral membrane proteins such as amyloid precursor protein (APP), being therefore a focus of interest for Alzheimer's disease research [20]. MTCH1 has two major isoforms, PSAPL and PSAPS, generated by alternative splicing. Both contain two apoptotic domains that can individually induce apoptosis when overexpressed at the outer mitochondrial membrane [21,22]. In 2013, Vural et al. [23] reported the presence of antibodies against MTCH1 in neuro-Behçet's disease, an inflammatory disorder, and in 2021, it was described that MTCH1 peptides are present in plasma from patients with sepsis [24]. MTCH1 is able to induce apoptosis in a manner not regulated by BCL-2 family proteins [25], although it requires SMAC [26]. In addition, Zeng et al. [27] showed that MTCH1 mediates presenilin 1-induced apoptosis in a γ-secretase-independent manner forming a complex with BAX. These authors suggest that MTCH1 functions as a receptor or anchor for BAX under certain apoptotic conditions when MTCH1 is present at endogenous levels, although it is able to induce apoptosis in a BCL-2 protein-independent manner when it is overexpressed [25,26]. In 2020, the same research group reported the participation of MTCH1 in apoptotic death induced by activation of the DR6 death receptor [28]. Rottiers et al. [10] reported the effects of altering the levels of Caenorhabditis elegans MTCH (referred to as MTCH-1 in their report) in lipid accumulation, causing developmental and fertility problems in the worm. Chen et al. [29] recently reported that MTCH1 upregulation is associated with cell proliferation, invasion, and migration of liver hepatocellular carcinoma, and suggested a possible role for MTCH1 in RNA splicing, although they did not comment on how a mitochondrial outer membrane protein could be involved in a process that takes place inside the nucleus. Very recently, as this manuscript was being prepared, Guna et al. [30] reported that MTCH2 is an outer membrane protein insertase.
To further elucidate the function of these proteins in whole organisms, we have used fruit fly Drosophila melanogaster as a model system. Drosophila has two putative Mtch1 orthologs named CG6851/Mtch and CG10920. However, it was not clear how these relate to human MTCH1 and MTCH2 or, indeed, if both are likely to encode functional Mtch orthologs. In this work, we first carried out phylogenetic analysis and looked at the tissue-level expression profile of both putative Drosophila Mtch orthologs. Then, we studied the role of Mtch in Drosophila, analyzing its knock down in cultured cells as well as characterizing in the whole animal the development and survival capabilities of two different P-element insertional mutants. Our results indicate that (a) CG6851 is likely the major Mtch ortholog in flies with CG10920 devoted to a testis-specific function, (b) Mtch is essential for proper fly development, (c) apoptosis is increased in homozygous mutant imaginal discs, and (d) reducing Mtch levels in cultured cells increases apoptosis. These results show unprecedented evidence on the induction of apoptotic signals upon depletion of Drosophila Mtch, contrary to previous observations in mammals, associated with improper fly development.
Materials and methodsDrosophila melanogaster mitochondrial carrier homolog 1, Mtch1 (CG6851) is located on chromosome arm 3L. Mutant lines MtchG20854 and MtchG8642 were obtained from the Bloomington Drosophila Stock Center (
Table 1 Specifications of
Stock IDa | Stock no.b | Genotype | Genomic insertion | Insertion with respect to Mtch gene |
G8642 | 27981 | y1 w*; P{EP} MtchG6842/TM3, Sb1, Ser1 | 3L, base 185035 | Coding sequence: 400 bases downstream of transcription start site |
G20854 | 28432 | y1 w*; P{EP} MtchG20854/TM3, Sb1, Ser1 | 3L, base 184663 | 5′UTR: 28 bases downstream of transcription start site |
aRefers to the identification number of the specific P element insertion.
bRefers to the number identifying the stock in the Bloomington Drosophila Stock Center.
Phylogenetic analysisSequences of Mtch orthologs from different species, including 12 sequenced drosophilids (Table S1), were aligned using clustal omega and phylogenetic tree files were constructed using clustalw2 phylogeny (EMBL-EBI). The trees were constructed from Newick files using itol [33].
Imaginal disc analysisWing imaginal disc staining and analysis was performed as described in [34], staining actin in red and activated caspase 3 in green. Nuclei were stained with ToPro3 (Thermo Fisher Scientific, Waltham, MA, USA) following instructions provided by the manufacturer, rabbit anti-caspase 3 (Cell Signaling Technology, Danvers, MA, USA) was used at 1 : 50 dilution and detected with Alexa Fluor 488-conjugated donkey anti-rabbit antibody (Thermo Fisher Scientific, Waltham, MA, USA) at 1 : 2000 dilution. Actin was detected with Alexa Fluor 647-conjugated phalloidin (Thermo Fisher Scientific, Waltham, MA, USA) at 1 : 50 dilution.
Schneider S2 cell cultureSchneider S2 cells were maintained in Schneider Drosophila Medium (Thermo Fisher Scientific #21720-024, Waltham, MA, USA) supplemented with 10% Fetal Bovine Serum (Thermo Fisher Scientific Corp., Waltham, MA, USA), penicillin G (100 IU·mL−1), and streptomycin (100 mg·mL−1) at 25 °C. Cells were diluted 1 : 4 twice a week.
MtchKnock-down of D. melanogaster Mtch gene (GenBank ID: 23787) was carried out in S2 cells according to Fernandez-Moreno et al. [35] with some modifications. dsRNA internal to Mtch mRNA was in vitro transcribed using the MEGAscript T7 transcription kit (Thermo Fisher Scientific, Waltham, MA, USA) using as template a 272 pb in size PCR-derived fragment (222 bp corresponding to nucleotides 254–476 of Mtch mRNA, plus T7 promoter sequences at each end) carrying the T7 promoter sequence at both ends (underlined): DMPSAPT7PROM1F-5′-GAATTAATACGACTCACTATAGGGAAGCACGCCCGCGCAGAGGAT-3′ as forward primer and DMPSAPT7PROM1R-5′-GAATTAATACGACTCACTATAGGGAAGCCGTCGATCCGCCGAATG-3′ as reverse primer. As a negative control, a 219 pb in size PCR-derived fragment flanked by the T7 promoter sequence (underlined) was also used as template to in vitro transcribe a dsRNA internal to bacterial lacZ gene. In this case, primers used were: T7 LacZ FW-5′-GAATTAATACGACTCACTATAGGGAGATCATGGTCATAGCTGTTTCCT-3′ as forward primer andT7 LacZ RV-5′-GAATTAATACGACTCACTATAGGGAGAAACCGCCTCTCCCCG-3′ as reverse primer.
For RNA interference, 30 μg of dsRNA were added directly to 4 × 106 S2 cells exponentially growing into 2 mL of Schneider Drosophila Medium supplemented with 10% fetal bovine serum without antibiotics. Plate was swirled by hand and cells were incubated at 25 °C for 1 h. Then, 3 mL of fresh complete medium were added. Twenty-four hours later, cells were harvested by centrifugation (240 g, 5 min), washed with PBS and resuspended in 5 mL of fresh complete media followed by an additional incubation at 25 °C for 48 h. Then, cells were spread out on three plates for the apoptosis assay, staurosporine treatment before apoptosis assay and RNA extraction and quantification.
The level of Mtch mRNA was analyzed by real-time quantitative PCR using three different pairs of primers:
Dm-qmtch1-FW-5′-GGTTAATGTTTGGATCCGCTTT-3′ with Dm-qmtch1-RV-5′-AACCCACCAATTTAGGAGCTAGAC-3′, Dm-qmtch2-FW-5′-CAGCTCCCTTTTCTGGCGGTCA-3′ with Dm-qmtch2-RV-5′-CATACCGGAGCCCGTCCGTG-3′ and Dm-qmtch3-FW-5′-GCTCCCTTTTCTGGCGGTCAC-3′ with Dm-qmtch3-RV-5′-GTCCGTGGTCGTCCAGCCTC-3′. For normalization of Mtch mRNA levels, quantification of the mRNA from three different genes was made using the following pairs of primers:
For Alpha-tub84B mRNA (FBtr0081639) primers aDmTub2-FW-5′-GGCATGGACTCCGGTGACGG-3′ and aDmTub2-RV-5′-GCCCACCAATGACGCTCCCA-3′ were used. For Actin42A mRNA (FBtr0086029) primers Actin42A2-FW-5′-GCCGCTTCAAGCTCGTCCCT-3′ and Actin42A2-RV-5′-AGCGATTCGGGGCAACGGAA-3′ were used. Finally, for the mRNA encoding the Polr2B (RNA polymerase II 140 kDa subunit; FBgn0262955) primers DmRpII140-FW2-5′-GGGCGTGTGCGCGTCCATTA-3′ and DmRpII140-RV2-5′-AAACGCCCATAGCTTGCTTACCCAT-3′ were used. Mtch mRNA interference were considered as the media of the measures of the three detectors (Dm-qmtch1, Dm-qmtch2 and Dm-qmtch3) normalized with Alpha-tub84B, Actin42A and Polr2B.
RNA was extracted with Trizol reagent (Merck, Darmstadt, Germany), and cDNA synthesized using the QuantiTect Reverse Transcription Kit (Qiagen, Venlo, The Netherlands), followed by SYBR green RTqPCR using an Applied Biosystems Step-One Plus real-time thermocycler (Thermo Fisher Scientific, Waltham, MA, USA), consisting of an initial 10 min denaturation step at 95 °C followed by 40 cycles of denaturation (15 s at 95 °C) and annealing/extension (1 min at 60 °C). The Mtch mRNA relative levels were determined by qPCR, normalizing to Alpha-tub84B (FBtr0081639), Actin42A (FBtr0086029) and Polr2B (RNA polymerase II 140 kDa subunit; FBgn0262955) mRNA levels and showing their media and standard deviation values.
Apoptosis assays by flow cytometryFor apoptosis assays, 7.5 × 105 S2 cells were treated with Mitostep + Annexin V-FITC Apoptosis Detection Kit (Immunostep ref.: KMAF-100T) following manufacturer recommendations and processed by flow cytometry. In some cases, apoptosis was induced by 5 μm Staurosporine for 20 h before the analysis. The fluorescence intensity of at least 10 000 events was determined in a FACScan cytometer (Cytomics FC 500MPL Beckman Coulter) using mpx (Beckman Coulter, Brea, CA, USA) acquisition software. Data were obtained as the media of six different experiments and their corresponding standard deviation.
Quantification and statistical analysisStatistical details of the experiments including statistical tests used, exact value of n, dispersion and precision measures (mean ± SD), and statistical significance are reported in the Figures and Figure Legends. The differences between two groups were analyzed using a two-tailed Student's t-test. All statistical analyses were performed using graphpad prism 8 software, La Jolla, CA, USA. A P value lower than 0.05 was considered significant.
ResultsIn order to identify Drosophila orthologs of the human proteins in sequence databases, we carried out a protein blast (National Center for Biotechnology Information) search using human MTCH1 protein sequence (large isoform, PSAP-LS,
Assignment of CG6851 and CG10920 to Mtch1 or Mtch2 is not trivial when just based on sequence homology, as concluded after several sequence alignments, summarized in Table 2. We must recall that human MTCH1 has two isoforms generated by alternative splicing that differ from each other in a stretch of 17 amino acids in an internal region of the protein, in such a way that we named PSAPS and PSAPL the short and large isoforms respectively [21]. Both isoforms have three putative translation start codons. Xu et al. [22] reported that PSAP is mainly translated from the second ATG, nevertheless alignment with Drosophila Mtch (CG6851, referred to as Mtch from now on) reveals that this protein is shorter than human MTCH1 and its amino terminal end aligns better with amino acids starting at the third ATG in human MTCH1, i.e., Mtch lacks amino terminal amino acids with respect to human MTCH1. Therefore, we also include MTCH1 protein sequences starting at the third ATG in Table 2 (Human PSAPS 3ATG) and use this protein in the alignments shown in Fig. 1 (HsMTCH1S3ATG). Since MTCH1 has internal localization signals these alternative initiation sites do not affect mitochondrial localization [21,22]. It can be concluded that both human MTCH1 and human MTCH2 have higher similarity and identity with Mtch than with CG10920. Mtch was considered as the Drosophila Mtch2 homolog by Grinberg et al. [36]. Drosophila Mtch proteins do not have a high similarity between them, indicating that conserved amino acids among each of them and the mammalian proteins are different from the ones conserved between both Drosophila proteins (Fig. 1). Since Robinson et al. [17] reported key amino acids in the mitochondrial carrier family and pinpointed some specific features of human MTCH2 sequences, we have marked those amino acids in Fig. 1 (Mtch sequence, underlined amino acids). It can be observed that most of those amino acids are conserved among all four proteins. In order to determine which of the two Drosophila proteins could be more important for fly physiology, we carried out a deeper analysis of these two proteins in drosophilids (see Table 3) and other organisms.
Table 2 Similarities and identities between human and
Similarity (%) | Identity (%) | |
Human PSAPL vs. human MTCH2 | 48.7 | 35.9 |
Human PSAPS vs. human MTCH2 | 50.7 | 37.3 |
Human PSAPS 3ATG vs. human MTCH2 | 60.9 | 44.8 |
Human PSAPL vs. Mtch | 38.8 | 26.2 |
Human PSAPS vs. Mtch | 40.2 | 27.3 |
Human PSAPS 3ATG vs. Mtch | 48.1 | 32.7 |
Human PSAPL vs. Dm CG10920 | 34.5 | 22 |
Human PSAPS vs. Dm CG10920 | 36 | 22.9 |
Human PSAPS 3ATG vs. Dm CG10920 | 29.9 | 19 |
Human Mtch2 vs. Mtch | 47.1 | 33.7 |
Human Mtch2 vs. Dm CG10920 | 33 | 23.5 |
Mtch vs. Dm CG10920 | 39.9 | 27.1 |
Fig. 1. Alignment of human and Drosophila proteins. Human Mtch1 (short spliced isoform starting at the third ATG, HsMTCH1S3ATG), human Mtch2 (HsMTCH2), Drosophila Mtch (DmMtch) and Drosophila CG10920 (DmCG10920) were aligned using clustalw2 with default settings. An asterisk indicates fully conserved residues; colon indicates strongly similar properties; period indicates weakly similar properties. Amino acids in bold indicate a peptide in human Mtch2 (140–161) that binds tightest to tBid [53]. Equivalent amino acids conserved in DmMtch are also marked in bold letters. Underlined amino acids in the DmMtch sequence refer to those that have been reported by Robinson et al. [17] to be conserved in mitochondrial carrier proteins, specifically referring to the Bos taurus ATP/ADP carrier shown in their Fig. 1. The proline (dark gray) that is part of the Px[D/E]xx[K/R] motif present in the SLC25 repeats, as well as polar and charged residues (light gray) highlighted by Guna et al. [30] are also marked in the human MTCH2 sequence.
Table 3 Mtch paralogs in drosophilids.
NCBI RefSeq | Species | Gene ID | Alias ID | Length | Chr | Muller | CDS introns | Current assembly | Location |
D. melanogaster | Mtch | CG6851 | 316 | 3L | D | 3 | Release 6 plus ISO1 MT (GCF_000001215.4) | ||
D. sechellia | LOC6610139 | GM14313 | 316 | 3L | D | 3 | ASM438219v1 (GCF_004382195.1) | ||
D. simulans | LOC6736203 | GD13550 | 316 | 3L | D | 3 | Prin_Dsim_3.1 (GCF_016746395.2) | ||
D. erecta | LOC6544643 | GG14697 | 316 | 3L | D | 3 | DereRS2 (GCF_003286155.1) | ||
D. yakuba | LOC6532190 | GE21060 | 316 | 3L | D | 3 | Prin_Dyak_Tai18E2_2.1 (GCF_016746365.2) | ||
D. ananassae | LOC6507488 | GF24859 | 318 | 2R | D | 3 | ASM1763931v2 (GCF_017639315.1) | ||
D. willistoni | LOC6643198 | GK21061 | 317 | XR | D | 3 | UCI_dwil_1.1 (GCF_018902025.1) | ||
D. willistoni | LOC6651365 | GK13597 | 318 | 3R | E/F | 0 | UCI_dwil_1.1 (GCF_018902025.1) | ||
D. persimilis | LOC6601056 | GL16153 | 314 | XR | D | 3 | DperRS2 (GCF_003286085.1) | ||
D. pseudoobscura | LOC4812188 | GA19905 | 314 | XR | D | 3 | UCI_Dpse_MV25 (GCF_009870125.1) | ||
D. grimshawi | LOC6556851 | GH15483 | 316 | 5 | D | 3 | ASM1815329v1 (GCF_018153295.1) | ||
D. grimshawi | LOC6566467 | GH13246 | 315 | 3 | B | 0 | ASM1815329v1 (GCF_018153295.1) | ||
D. mojavensis | LOC6586440 | GI16759 | 316 | 4 | D | 3 | ASM1815372v1 (GCF_018153725.1) | ||
D. virilis | LOC6622585 | GJ12504 | 316 | 3 | D | 3 | DvirRS2 (GCF_003285735.1) | ||
D. melanogaster | CG10920 | CG10920 | 397 | X | A | 0 | Release 6 plus ISO1 MT (GCF_000001215.4) | ||
D. sechellia | LOC6620243 | GM11973 | 397 | X | A | 0 | ASM438219v1 (GCF_004382195.1) | ||
D. simulans | LOC6725384 | GD16147 | 437a/397 | X | A | 0 | Prin_Dsim_3.1 (GCF_016746395.2) | ||
D. erecta | LOC6551654 | GG17610 | 395 | X | A | 0 | DereRS2 (GCF_003286155.1) | ||
D. yakuba | LOC6525401 | GE17510 | 390 | X | A | 0 | Prin_Dyak_Tai18E2_2.1 (GCF_016746365.2) | ||
D. ananassae | LOC6503933 | GF21249 | 452 | XL | A | 0 | ASM1763931v2 (GCF_017639315.1) | ||
D. willistoni | LOC6649061 | GK18865 | 399 | XL | A | 1 | UCI_dwil_1.1 (GCF_018902025.1) | ||
D. persimilis | LOC6597637 | GL14592 | 383 | XL | A | 0 | DperRS2 (GCF_003286085.1) | ||
D. pseudoobscura | LOC6901822 | GA24120 | 389 | XL | A | 0 | UCI_Dpse_MV25 (GCF_009870125.1) | ||
D. grimshawi | LOC6565377 | GH12126 | 381 | X | A | 0 | ASM1815329v1 (GCF_018153295.1) | ||
D. mojavensis | LOC6585432 | GI16212 | 350 | X | A | 0 | ASM1815372v1 (GCF_018153725.1) | ||
D. virilis | LOC6634654 | GJ15674 | 366 | X | A | 0 | DvirRS2 (GCF_003285735.1) |
aProbably translated in downstream initiation codon/annotation error.
Most (but not all) vertebrate species contain two copies of Mtch homologs, one of which is generally related to human MTCH1 and the other one, to MTCH2 (Fig. 2). To investigate if the fly Mtch orthologs can be grouped similarly, we aligned sequences from Mtch orthologs in 12 sequenced drosophilids with a selected group of annotated vertebrate and invertebrate species. As shown in Fig. 2A, the organization in MTCH1 or MTCH2–like genes is very clear among vertebrates. However, the invertebrate species (which in general contain one MTCH homolog) cannot be distinctively annotated as homologs of MTCH1 or MTCH2. This is also the case with Mtch-like proteins in drosophilids, where the 2-3 homologs are clearly separate from each other within invertebrates (CG6851-like and CG10920-like groups) but show no specific homology for either human MTCH1 or MTCH2. Further analysis of drosophilid CG6851-like and CG10920-like groups confirmed that they form clear phylogenetic/syntenic groups (Fig. 2B) that recapitulate the general phylogeny of drosophilids.
Fig. 2. Phylogenetic analysis of Mtch orthologs. (A) Radial phylogenetic tree of Mtch orthologs in vertebrates and invertebrates (including 12 sequenced drosophilids). Most vertebrate species contain two copies of Mtch homologs, one of which related to human MTCH1 and the other to human MTCH2. Exceptions (gray font) are cartilaginous fishes (such as sharks) that contain one MTCH1-like gene, and bony fishes (teleosts) and amphibians that contain one MTCH2-like gene. The invertebrate species generally contain one Mtch homolog. However, in drosophilids there are 2-3 Mtch homologs which we call CG6851-like and CG10920-like groups. (B) Detailed phylogram and the syntenic relationships (Muller elements, colored dots) among the Mtch orthologs of the 12 sequenced fly genomes. Because karyotypes vary in different Drosophila species, a six-element Muller element designation (A–F) is used as a standardized notation for the syntenic relationship, i.e. conserved chromosome regions among species. Additionally, a view of the phylogenetic relationships of the species in different groups is shown (colored bars). All drosophilid species shown contain two Mtch orthologs, except Dgri and Dwil which each have three orthologs. The Mtch orthologs can be divided clearly in two phylogenetic/syntenic groups, one being “CG6851-like” (Muller D) and another “CG10920-like” (Muller A). The third Mtch orthologs in Dgri (GH13246) and Dwil (Gk13597) are phylogenetically CG10920-like but located in different Muller elements suggesting more recent gene duplication in these species.
To gain insight into the potential biological significance of the two Mtch homologs in flies we investigated where and at which level these genes are expressed using FlyAtlas2 [37]. As shown in Fig. S1, CG6851 was expressed at high levels in all larval (panel A) and adult (panels B and C) tissues examined, whereas CG10920 was basically testis-specific and not expressed in females or in larval tissues. Although this does not necessarily imply that CG10920 function is dispensable in some specific tissues, we reasoned that CG6851 is a more likely candidate for whole-organism investigation of Mtch function, and therefore we focused our work on this protein.
Deletion ofTo study the role of Mtch in Drosophila, we analyzed two different P-element insertional mutants, lines G8642 and G20854. From here on we will refer to these mutants as mutants 1 and 2, respectively. The precise genotypes of these stocks are shown in Table 1. In mutant 1 P-element insertion disrupts the gene in the coding sequence, just after leucine at position 57, and is likely to result in complete loss of Mtch function. On the other hand, mutant 2 presents the P-element inserted in the region corresponding to the 5′ UTR of the transcript, which is often associated with a loss or a severe reduction in gene expression. Accordingly, the observed phenotypes are much stronger in mutant 1, further confirming its loss of function (Fig. 3).
Fig. 3. Phenotypes of wild type, mutant and revertant larva. (A) Representative images of each phenotype. (B) Graph indicating the lengths, in mm, of larva (L3) from each type averaged in each case from 6 to 12 individuals (average length is indicated inside each bar). Error bars represent standard deviation. Yw, wild type; BL-27981 (mutant 1), homozygote larva of this mutant; 27981 Jo, revertant of this mutant; BL-28432 (mutant 2), homozygote larva of this mutant; 28432 Jo, revertant of this mutant. Statistical analysis was carried out using a two-tailed test, with N = 3, where each N represents the average of 6 to 12 larva analyzed on different days. **P [less than] 0.0005. Scale bar in A is 0.5 mm.
Homozygous mutant larvae from both lines showed a clear phenotypic difference with respect to wild type flies (Fig. 3). They were shorter and slimmer, a phenotype often associated with mitochondrial alterations [38,39]. Homozygous mutant 1 progeny did not survive beyond larval stage 3, whereas mutant 2 homozygous animals reached pupal stages, with very few of them eclosing. In the latter case, the few adult flies that emerged died soon afterward. This is consistent with the expected severity of the mutations based on P-element insertion sites in the coding region (mutant 1) and 5′ untranslated region (mutant 2).
To confirm that this phenotypic alteration was caused by defects in Mtch expression, the P-elements were genetically removed. Revertants had a wild type phenotype, development and apparent life span, indicating that the described phenotype was caused by Mtch inactivation or reduced expression (Fig. 3).
Knocking out Mtch increases cell apoptosis in wing imaginal discsHuman MTCH1 has been reported to induce apoptosis when overexpressed in cultured cells [40] and knocking out MTCH2 in mice reduces apoptosis mediated by BAX/BAK and induced by tBID [5], therefore we hypothesized that failure to complete development in Drosophila upon Mtch inactivation could be due to reduced apoptosis during pupation. Since larvae from mutant 2 were able to enter the pupal stage we analyzed wing imaginal discs to identify possible alterations. The discs were stained with phalloidin (red), ToPro3 (blue), and an antibody against activated caspase 3 (green). All imaginal discs analyzed (at least 12 in each experiment) from mutant flies were around half the size of their wild counterparts. Furthermore, staining for activated caspase 3, an indicator of cell apoptosis, showed an increase in apoptotic cell death in mutant flies as compared to wild type counterparts (Fig. 4). These results show that blocking Mtch in flies increases apoptosis in imaginal discs, indicating the opposite effect to what has been described in mammalian cells [40].
Fig. 4. Increase in apoptosis in imaginal discs. Wing imaginal discs were isolated from wild type pupa (A) and from BL-28432 homozygotes (B), stained for Actin (red) and activated caspase 3 (green) and photographed with a Nikon 90i microscope at 400× magnification. Representative images of at least 12 analyzed imaginal discs are shown. The scale bar is 100 μm.
Since many experiments with human MTCH1 have been carried out in cultured cells, we decided to analyze the effects of knocking down Mtch directly in Drosophila cultured cells, performing RNA interference (RNAi) assays in Schneider cells. Double-stranded RNA (dsRNA) was designed with a sequence comprising over 200 bp of the 5′ side of Mtch mRNA. A dsRNA designed against bacterial LacZ was used as negative control [41]. Cells were treated with the dsRNA for 24 h and then divided in three sets. One of these was used for RNA extraction and subsequent analysis by real-time PCR to measure Mtch mRNA levels. The other two sets were used to detect apoptosis in the absence or presence of staurosporine, using annexin-V and propidium iodide. Upon RNA interference, the levels of Mtch mRNA were reduced around 90% with respect to a control (a similar treatment using dsRNA against bacterial LacZ; Fig. 5A). The levels of the mRNAs of three other genes, Alpha-tub84B, Actin42A, and Polr2B, were also measured and used to normalize Mtch mRNA levels among different assays.
Fig. 5. Effect of RNA interference in cultured cells. (A) Mtch mRNA levels under standard and interference situations. The amount of the mRNA was determined by qPCR in exponentially growing Schneider SL2 cells in presence of dsRNA internal to LacZ, as a negative control, or Mtch dsRNA as indicated in Materials and methods. n = 6 independent experiments, mean ± SD are shown. ***P value [less than] 0.001. (B) Quantification of viable cells and cells in early apoptosis in a Mtch interference situation and control either in presence and absence of staurosporine. Data are shown as a mean ± SD for n = 6 independent experiments. A statistical two-tailed t-student test was carried out. **P value [less than] 0.01. ns, not significant.
Results, shown in Fig. 5B, indicate an increase in apoptotic cells (annexin V-positive, propidium iodide-negative) when Mtch levels are reduced with respect to wild type cells. This effect is stronger when cells are treated with the apoptosis inducer staurosporine. This is in perfect agreement with what we observed in imaginal discs by detection of activated caspase 3, indicating that depletion of Mtch increases apoptosis both in cultured cells and in developing flies, which explains the failure to complete pupation.
DiscussionThe function of mammalian MTCH1 has remained elusive for years and only recently have some reports shed light onto its cellular function. We have shown here that significatively decreasing Drosophila Mtch function in whole flies or in cultured cells increases apoptosis. The increase in apoptosis appears to be associated with failure of fly metamorphosis, leading to death at larval or pupal stages. These results are striking and unexpected considering the data available from human cultured cells, where overexpression of MTCH1 induces apoptosis.
Of the two fly Mtch orthologs, CG6851 and CG10920, the former is the best candidate to be considered the Drosophila Mtch since the expression of the latter is confined almost completely to testis and lacks introns, being therefore likely originated by reverse transcription later during evolution. Furthermore, neither Drosophila protein could be ascribed to Mtch1 or Mtch2 only based on sequence homology. In fact, the Drosophila proteins are not significantly more similar to each other than they are to their mammalian orthologs, although CG6851 was considered the Drosophila Mtch2 in a former publication [36], and this is reinforced by DRSC Integrative Orthology Prediction Tool data available in FlyBase (
As a target for tBID in mitochondria, knocking out MTCH2 is expected to reduce apoptosis initiated by the extrinsic pathway and mediated by tBID, and so was found when it was knocked out conditionally in mouse liver, although the conventional knockouts were embryonically lethal in homozygosis [5]. Lack of MTCH2 did not affect apoptosis induced by other pro-apoptotic BCL-2 family members. Zhang et al. [28] reported that MTCH1 is involved in apoptosis mediated by the death receptor DR6, which interacts with MTCH1 in mitochondria and with BAX in the cytosol, suggesting that BAX could be transferred from the former to the latter but with no apparent mediation of BID. The question arises whether Mtch could be playing in Drosophila a similar role to human MTCH2, as a target for a BID-like protein. Nevertheless, only two BCL-2 family members have been reported in Drosophila: Debcl (also known as Drob-1, dBorg-1 and dBok) and Buffy (also known as dBorg-2) which is anti-apoptotic [42-47]. In one report Debcl was found to be protective against polyglutamine-induced toxicity in Drosophila, and antagonized by Buffy [48]. Both are structurally related to mammalian BOK, containing BH1-BH3 domains, and Debcl is considered to be the ortholog of BAX/BAK [49] whereas Buffy has a function similar to that of BCL-XL. No BID-like protein is present in Drosophila, and therefore no candidate for binding to Drosophila Mtch has so far been identified (to our knowledge this is the first study of Drosophila Mtch). Furthermore, Drosophila BCL-2-like proteins have been reported to be dispensable for normal development [50]. A later report indicated that Debcl, although not required for gross development and lifespan, was required for pruning cells in the developing central nervous system [49]. Considering these reports and the fact that knocking down Mtch in flies is developmentally lethal, it is unlikely that Mtch is acting in Drosophila together with any of the two BCL-2 family members, i.e., its mechanism of action appears to be different from that of MTCH2 in mammals with respect to tBID binding, and also to that of MTCH1 considering its reported interaction with BAX [28]. We must also recall that mammalian MTCH2 was first reported as MIMP, Met-induced mitochondrial protein, and described to be upregulated by Met-HGF/SF signal transduction, leading to mitochondrial depolarization [7]. These authors later published that MIMP overexpression reduces Met-HGF/SF-induced proliferation and scattering by attenuating and altering the downstream signaling of Met, linking a tyrosine kinase growth factor receptor and a mitochondrial carrier homolog that regulates cellular growth, motility, and tumorigenicity. It is unknown whether Drosophila Mtch could be playing a similar role.
MTCH2 has been also involved in lipid metabolism [8,9], and therefore it is possible that Drosophila Mtch could also be involved in some lipid metabolism-related processes. To our knowledge, no link between the apoptotic function of mammalian MTCH2 and its implication in lipid metabolism has been described, although a possible role for MTCH2 in death related to metabolism regulation cannot be ruled out [51], neither for Drosophila Mtch. In support of this possibility, a direct link between glucose metabolism and apoptosis has been reported [52].
The interaction between MTCH2 and tBID at the molecular level has been studied [53]. The MTCH2 peptide that shows the strongest interaction with tBID corresponds to amino acids 140 to 161 in human MTCH2, and 13 out of these 22 amino acids are conserved in Drosophila Mtch (see Fig. 1 and Table 2), implying a high degree of conservation (59%) in this stretch, well above the 33.7% identity these two proteins show overall. This level of conservation suggests an important role for this region in protein activity, and it could be involved in interactions with other yet-to-know Drosophila proteins as it does with tBID in its mammalian counterpart. Nevertheless, we must also consider that human MTCH1 contains 14 conserved amino acids in this stretch of 22, and so far no interaction of tBID with MTCH1 has been reported.
As already mentioned, Zeng et al. [27] showed that MTCH1 mediates presenilin 1 (PS1)-induced apoptosis, with an MTCH-BAX complex formed upon stimulation by wild type PS1 or gamma-secretase-inactive PS1, suggesting that MTCH1 functions as a receptor for BAX under certain apoptotic conditions. In the putative scenario that Drosophila Mtch worked as a receptor or anchor for the proapoptotic protein Debcl, we would expect to see reduced, instead of increased, levels of apoptosis upon knocking down Mtch1.
After many years with several researchers trying to identify a definitive function for the MTCH family of proteins it appears that Guna et al. [30] have finally pointed to their major function as integrases. Nevertheless, upon consideration of the several reports about these proteins it appears that they may be playing other roles in cells apart from insertases. This was also suggested by Guna et al. when they stated that their finding “now provides a molecular explanation for its pleiotropic phenotypes, many of which can be directly ascribed to defects in biogenesis of MTCH2 substrates”, i.e. not all the phenotypes described so far can be directly ascribed to the role of these proteins as insertases. The fact that overexpression of MTCH1, but not MTCH2 (except in one report) is able to induce apoptosis in a BAX/BAK independent manner points in this direction. Also, MTCH1 is able to interact with BAX, but BAX, as well as BCL-XL, is able to insert into liposomes in the absence of MTCH proteins but depending on tBID [54]. If MTCH proteins are not required for BAX insertion into membranes but BAX interacts with MTCH1 [28] then it appears likely that MTCH1 has a role in apoptosis that does not depend, at least directly, on its insertase activity, which is also supported by the fact that MTCH2 is a target for tBID in mitochondria [5], although tBID can insert into liposomes in the absence of other proteins [54]. MTCH1 fragments are able to induce apoptosis when directed to the outer membrane by fusion to the TMD of BCL-XL [25], also suggesting other roles for these proteins, as well as the report of Zhang et al. [28] that MTCH1 functions as a receptor for DR6 in mitochondria. In the case of MTCH2, although its induction of apoptosis upon overexpression was reported once [55], Guna et al. [30] showed that MTCH2 overexpression in human K562 leukemia cells sensitizes them to imatinib-induced apoptosis, which is dependent on its insertase activity.
In summary, we show here that depletion of Drosophila Mtch increases apoptosis in flies as well as in cultured cells, being responsible for developmental failure. These results are in contrast with what has been described for the human orthologs, since overexpression of human MTCH1 in cells induces apoptosis and its depletion has an additive effect to that of MTCH2 on biogenesis of many mitochondrial tail-anchored proteins. These, and other, findings point towards additional functions of these proteins apart from that as insertases, which prompts further research in this interesting family of proteins.
AcknowledgementsWe thank Ramón Hurtado-Guerrero for useful advice. We thank Manuel Calleja for the gift of the Δ 2-3 line and for useful advice. JMT was supported by the Government of Spain (RYC-2011-08363). This work was supported by Grant of the Ministerio de Ciencia e Innovación, government of Spain (PID2019-110320RB-I0) to MAF-M; and by BFU2009-11800 (MICINN, Spain) and UZ2010-BIO-03 (Universidad de Zaragoza, Spain) to JAC. The funding sources had no involvement in the conception, preparation or publication of this work.
Conflict of interestThe authors declare no conflict of interest.
Peer reviewThe peer review history for this article is available at
Data will be made available from the corresponding author upon reasonable request.
Author contributionsMAF-M and JAC conceived and supervised the study; JJA supervised and carried out experiments with flies; JMT realized sequence analyses in drosophilids and other organisms; CG, LM-S and PC carried out most of the experiments; JAC wrote the manuscript with inputs from JJA, JMT and MAF-M.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Mitochondrial carrier homologs 1 (MTCH1) and 2 (MTCH2) are orphan members of the mitochondrial transporter family SLC25. Human MTCH1 is also known as presenilin 1-associated protein, PSAP. MTCH2 is a receptor for tBid and is related to lipid metabolism. Both proteins have been recently described as protein insertases of the outer mitochondrial membrane. We have depleted Mtch in
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Departamento de Bioquímica & Instituto de Investigaciones Biomédicas “Alberto Sols”, The Autonomous University of Madrid-Consejo Superior de Investigaciones Científicas, Spain
2 LAGENBIO, Departamento de Anatomía, Embriología y Genética Animal, Facultad de Veterinaria, Instituto Agroalimentario de Aragón (IA2), Universidad de Zaragoza, Spain; IIS Aragón, Zaragoza, Spain; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
3 Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Facultad de Medicina, UAM, Madrid, Spain; Departamento de Bioquímica & Instituto de Investigaciones Biomédicas Sols-Morreale, The Autonomous University of Madrid-Consejo Superior de Investigaciones Científicas, Madrid, Spain
4 IIS Aragón, Zaragoza, Spain; Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Spain; Department of Biochemistry and Molecular and Cellular Biology, School of Sciences, University of Zaragoza, Spain